Actively Recruiting
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
Led by Peking University Cancer Hospital & Institute · Updated on 2026-03-04
20
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the ability of \[68Ga\]N188 to detect nectin-4 overexpression in patients with urothelial carcinoma, especially in patients with recurrent or advanced bladder cancer.
CONDITIONS
Official Title
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years, male or female
- Normal heart function
- Estimated survival of at least 12 weeks
- Good compliance with follow-up
- At least one measurable target lesion according to RECIST 1.1 criteria
- Women of childbearing age (15-49 years) must have a negative pregnancy test within 7 days before starting the test
- Fertile men and women must agree to use effective contraception during the study and for 3 months after
- Recommended by clinicians for PET/CT tumor diagnostic staging
- Able to understand and voluntarily consent to participate
You will not qualify if you...
- Serious abnormalities of liver, kidney, or blood
- Pregnant patients
- Pregnant or lactating women
- Unable to lie flat for half an hour
- Refusal to participate
- Claustrophobia or other mental diseases
- Other conditions deemed unsuitable by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142
Actively Recruiting
Research Team
Z
Zhi Yang, Professor
CONTACT
H
Hua Zhu, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here